Glycosaminoglycans Are Interactants of Langerin: Comparison with gp120 Highlights an Unexpected Calcium-Independent Binding Mode

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Chabrol, Eric ^a,b,c   Nurisso, Alessandra ^d   Daina, Antoine ^d,e   Vassal Stermann, Emilie ^a,b,c   Thepaut, Michel ^a,b,c   Girard, Eric ^a,b,c   Vivès, Romain R ^b,c,e   Fieschi, Franck ^a,b,c,f  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^b CNRS   (France)

^c CEA GRENOBLE   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^f INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLYCOPROTEIN GP 120; HEPARIN; IDURONIC ACID; LANGERIN;

ARTICLE; BINDING KINETICS; BINDING SITE; BIOLOGICAL FUNCTIONS; CONTROLLED STUDY; MOLECULAR DOCKING; MOLECULAR MECHANICS; MOLECULAR MODEL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

ANTIGENS, CD; CALCIUM; EPIDERMIS; GLYCOSAMINOGLYCANS; HEPARIN; HIV ENVELOPE PROTEIN GP120; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MUCOUS MEMBRANE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SOFTWARE;

MAMMALIA;

EID: 84870586527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050722     Document Type: Article

References (49)

1. Valladeau J, Duvert-Frances V, Pin JJ, Dezutter-Dambuyant C, Vincent C, et al. (1999) The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 29: 2695-2704.
2. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, et al. (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81.
3. de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MAWP, et al. (2007) Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 13: 367-371.
4. Tabarani G, Thépaut M, Stroebel D, Ebel C, Vivès C, et al. (2009) DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain. J Biol Chem 284: 21229-21240.
5. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
6. Solomon T, (2010) The multiple facets of HIV attachment to dendritic cell lectins. Cellular Microbiology 12: 1553-1561.
7. de Witte L, Nabatov A, Geijtenbeek TBH, (2008) Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med 14: 12-19.
8. Balzarini J, (2007) Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol 5: 583-597.
9. Tabarani G, Reina JJ, Ebel C, Vivès C, Lortat-Jacob H, et al. (2006) Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding. FEBS Lett 580: 2402-2408.
10. Reina JJ, Sattin S, Invernizzi D, Mari S, Martinez-Prats L, et al. (2007) 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity. ChemMedChem 2: 1030-1036.
11. Borrok MJ, Kiessling LL, (2007) Non-carbohydrate inhibitors of the lectin DC-SIGN. J Am Chem Soc 129: 12780-12785.
12. Becer CR, Gibson MI, Geng J, Ilyas R, Wallis R, et al. (2010) High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein. J Am Chem Soc 132: 15130-15132.
13. Andreini M, Doknic D, Sutkeviciute I, Reina JJ, Duan J, et al. (2011) Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin. Org Biomol Chem 9: 5778-5786.
14. Martínez-Avila O, Bedoya LM, Marradi M, Clavel C, Alcamí J, et al. (2009) Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells. ChemBioChem 10: 1806-1809.
15. Berzi A, Reina JJ, Ottria R, Sutkeviciute I, Antonazzo P, et al. (2012) A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models. AIDS 26: 127-137.
16. Feinberg H, Powlesland AS, Taylor ME, Weis WI, (2010) Trimeric Structure of Langerin. J Biol Chem 285: 13285-13293.
17. Feinberg H, Taylor ME, Razi N, Mcbride R, Knirel YA, et al. (2011) Structural basis for langerin recognition of diverse pathogen and mammalian glycans through a single binding site. J Mol Biol 405: 1027-1039.
18. Holla A, Skerra A, (2011) Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin. Protein Engineering Design and Selection 24: 659-669.
19. Guo Y, Feinberg H, Conroy E, Mitchell DA, Alvarez R, et al. (2004) Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 11: 591-598.
20. Galustian C, Park CG, Chai W, Kiso M, Bruening SA, et al. (2004) High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin. Int Immunol 16: 853-866.
21. Tateno H, Ohnishi K, Yabe R, Hayatsu N, Sato T, et al. (2010) Dual Specificity of Langerin to Sulfated and Mannosylated Glycans via a Single C-type Carbohydrate Recognition Domain. J Biol Chem 285: 6390-6400.
22. Bernfield M, Kokenyesi R, Kato M, (1992) Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans- Annual Review of Cell Biology. 8(1): 365-393.
23. Catlow KR, Deakin JA, Wei Z, Delehedde M, Fernig DG, et al. (2008) Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J Biol Chem 283: 5235-5248.
24. Grosdidier A, Zoete V, Michielin O, (2009) Blind docking of 260 protein-ligand complexes with EADock 2.0. J Comput Chem 30: 2021-2030.
25. Mikhailov D, Linhardt RJ, Mayo KH, (1997) NMR solution conformation of heparin-derived hexasaccharide. Biochem J 328 (Pt 1): 51-61.
26. Turville S, Cameron P, Handley A, Lin G, Pöhlmann S, et al. (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3: 975-983.
27. Thépaut M, Valladeau J, Nurisso A, Kahn R, Arnou B, et al. (2009) Structural studies of langerin and Birbeck granule: a macromolecular organization model. Biochemistry 48: 2684-2698.
28. Kissenpfennig A, Ait-Yahia S, Clair-Moninot V, Stossel H, Badell E, et al. (2005) Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol 25: 88-99.
29. Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, et al. (2004) Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 113: 701-708.
30. Valladeau J, Caux C, Lebecque S, Saeland S, (2001) [Langerin: a new lectin specific for Langerhans cells induces the formation of Birbeck granules]. Pathol Biol (Paris) 49: 454-455.
31. Hijazi K, Wang Y, Scala C, Jeffs S, Longstaff C, et al. (2011) DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4. PLoS ONE 6: e28307.
32. Esko JD, Kimata K, Lindahl U (2009) Proteoglycans and Sulfated Glycosaminoglycans. Essentials of glycobiology. 2nd edition, ed Varki A CR, Esko JD, Freeze H, Hart G, Marth J (Cold Spring Harbor Laboratory Press).
33. Bousarghin L, Hubert P, Franzen E, Jacobs N, Boniver J, et al. (2005) Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells. J Gen Virol 86: 1297-1305.
34. de Witte L, Zoughlami Y, Aengeneyndt B, David G, van Kooyk Y, et al. (2007) Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation. Immunobiology 212: 679-691.
35. Chatwell L, Holla A, Kaufer BB, Skerra A, (2008) The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site. Mol Immunol 45: 1981-1994.
36. Tateno H, Ohnishi K, Yabe R, Hayatsu N, Sato T, et al. (2010) Dual Specificity of Langerin to Sulfated and Mannosylated Glycans via a Single C-type Carbohydrate Recognition Domain. J Biol Chem 285: 6390-6400.
37. O'Sullivan GM, Boswell CM, Halliday GM, (2000) Langerhans cell migration is modulated by N-sulfated glucosamine moieties in heparin. Exp Dermatol 9: 25-33.
38. Thépaut M, Vivès C, Pompidor G, Kahn R, Fieschi F, (2008) Overproduction, purification and preliminary crystallographic analysis of the carbohydrate-recognition domain of human langerin. Acta Crystallogr F Struct Biol Cryst Commun 64: 115-118.
39. Vivès RR, Sadir R, Imberty A, Rencurosi A, Lortat-Jacob H, (2002) A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41: 14779-14789.
40. Frese M-A, Milz F, Dick M, Lamanna WC, Dierks T, (2009) Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain. J Biol Chem 284: 28033-28044.
41. Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT, (1998) Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 273: 22936-22942.
42. Waldherr-Teschner M, Goetze T, Heiden W, Knoblauch M, Vollhardt H, et al. (1992) MOLCAD-Computer Aided Visualization and Manipulation of Models in Molecular Science. Advances in Scientific Visualization. Springer, Heidelberg. 58-67.
43. Grosdidier A, Zoete V, Michielin O, (2011) SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 39: W270-W277.
44. Halgren T, (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94- Halgren- 1998- Journal of Computational Chemistry- Wiley Online Library. J Comput Chem 17: 490-519.
45. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, et al. (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4: 187-217 doi:10.1002/jcc.540040211.
46. Imberty A, Bettler E, Karababa M, Mazeau K, Petrova P, et al. (1999) Building sugars: The sweet part of structural biology. In: Kolaskar AS, editor. Perspectives in Structural Biology. Hyderabad: Indian Academy of Sciences and Universities Press. 392-409.
47. Clark M, Cramer RDI, van den Opdenbosch N, (1989) Validation of the general purpose Tripos 5.2 force field. J Comput Chem 10: 982-1012.
48. Jones G, Willett P, Glen RC, Leach AR, Taylor R, (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267: 727-748.
49. Cros S, Petitou M, Sizun P, Pérez S, Imberty A, (1997) Combined NMR and molecular modeling study of an iduronic acid-containing trisaccharide related to antithrombotic heparin fragments. Bioorg Med Chem 5: 1301-1309.